Previous studies found that activation of Nurr1 using agonists provided important neuroprotective effects against neuroinflammation in Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis [67, 71–73]. Here, NR4A2 is linked to Parkinson disease.